4730 J ournal of Medicinal Chemistry, 2004, Vol. 47, No. 19
Tavares et al.
Synthase Kinase 3 Negatively Regulates Both DNA-Binding and
Transcriptional Activities of Heatshock Factor 1. J . Biol. Chem.
2000, 275, 29147-29152. (f) Hedgepeth, C. M.; Conrad, L. J .;
Zhang, J .; Huang, H. C.; Lee, V. M.; Klein, P. S. Activation of
A. N.; Ehrbar, U.; Hansen, B. F. Synthesis and in Vitro
Characterization of 1-(4-Aminofurazan-3-yl)-5-dialkylaminom-
ethyl-1H-[1,2,3]triazole-4-carboxylic Acid Derivatives. A New
Class of Selective GSK-3 Inhibitors. J . Med. Chem. 2003, 46,
3333-3341. (i) Witherington, J .; Bordas, V.; Garland, S. L.;
Hickey, D. M. B.; Ife, R. J .; Liddle, J .; Saunders: M.; Smith, D.
G.; Ward, R. W. 5-Aryl-pyrazolo [3,4-b]pyridines: Potent Inhibi-
tors of Glycogen Synthase Kinase-3 (GSK-3). Bioorg. Med. Chem.
Lett. 2003, 13, 1577-1580. (j) Bax, B.; Carter, P. S.; Lewis, C.;
Guy, A. R.; Bridges, A.; Tanner, R.; Pettman, G.; Mannix, C.;
Culbert, A. A.; Brown, M. J . B.; Smith, D. G.; Reith, A. D. The
Structure of Phosphorylated GSK-3â Complexed with a Peptide,
FRATtide, That Inhibits â-Catenin Phosphorylation. Structure
2001, 9, 1143-1152. (k) Witherington, J .; Bordas, V.; Haigh, D.;
Hickey, D. M. B.; Ife, R. J .; Rawlings, A. D.; Slingsby, B. P.;
Smith, D. G.; Ward, R. W. 5-Aryl-pyrazolo [3,4-b]pyridazines:
Potent Inhibitors of Glycogen Synthase Kinase-3 (GSK-3).
Bioorg. Med. Chem. Lett. 2003, 13, 1581-1584. (l) Olesen, P.
H.; Sorensen, A. R.; Urso, B.; Kurtzhals, P.; Bowler, A. N.;
Ehrbar, U.; Hansen, B. F. Synthesis and in Vitro Characteriza-
tion of1-(4-Aminofurazan-3-yl)-5-dialkylaminomethyl-1-H-[1,2,3]-
triazole-4-carboxylic Acid Derivatives. A new Class of Selective
GSK-3 Inhibitors. J . Med. Chem. 2003, 46, 3333-3341. (m) Kuo,
G.-H,; Prouty, C.; DeAngelis, A.; Shen, L.; O’Neill, D. J .; Shah,
C.; Connolly, P. J .; Murray, W. V.; Conway, B. R.; Cheung, P.;
Westover, L.; Xu, J . Z.; Look, R. A.; Demarest, K. T.; Emanuel,
S.; Middleton, S. A.; J olliffe, L.; Beavers, M. P.; Chen, X.
Synthesis and Discovery of Macrocyclic Polyoxygenated Bis-7-
azaindolyimaleimides As A Novel Series of Potent and Highly
Selective Glycogen Synthase Kinase-3â Inhibitors. J . Med.
Chem. 2003, 46, 4021-4031. (n) Bramson, N. H.; Corona, J .;
Davis, S. T.; Dickerson, S. H.; Edelstein, M.; Frye, S. V.; Gampe,
R. T.; Harris, P. A. J r.; Hassell, A.; Holmes, W. D.; Hunter, R.
N.; Lackey, K. E.; Lovejoy, B.; Luzzio, M. J .; Montana, V.;
Rocque, W. J .; Rusnak, D.; Shewchuk, L.; Veal, J . M.; Walker,
D. H.; Kuyper, L. F. Oxindole-Based Inhibitors of Cyclin-
Dependent Kinase 2 (CDK2): Design, Synthesis, Enzymatic
Activities, and X-ray Crystallographic Analysis. J . Med. Chem.
2001, 44, 4339-4358.
the Wnt Signaling Pathway:
A Molecular Mechanism for
Lithium Action. Dev. Biol. 1997, 185, 82-91. (g) Rubinfeld, B.;
Albert, I.; Porfiri, R.; Fiol, C.; Munemitsu, S.; Polakis, P. Binding
of GSK3 to the APC-â-Catenin Complex and Regulation of
Complex Assembly. Science 1996, 272, 1023-1026. (h) Sa-
kanaka, C.; Weiss, J . B.; Williams, L. T. Bridging of â-Catenin
and Glycogen Synthase-3 by Axin and Inhibition of â-Catenin
Mediated Transcription. Proc. Natl. Acad. Sci. U.S.A. 1998, 95,
3020-3023. (i) Yost, C.; Farr, G. H.; Pierce, S. B.; Ferkey, D.
M.; Chen, M. M.; Kimelman, D. GBP, an Inhibitor of GSK-3, Is
Implicated in Xenopus Development and Oncogenesis. Cell 1998,
93, 1031-1041. (j) Hoeflich, K. P.; Luo, J .; Rubie, E. A.; Tsao,
M.-S.; J in, O.; Woodgett, J . R. Requirement for Glycogen
Synthase Kinase-3 in Cell Survival and NF-κB Activation.
Nature 2000, 406, 86-90. (k) Henriksson, M.; Bakardjiev, A.;
Klein, G.; Luscher, B. Phosphorylation Sites Mapping the
N-Terminal Domain of c-myc Modulates Its Transforming
Potential. Oncogene 1993, 8, 3199-3209. (l) Pulverer, B. J .;
Fisher, C.; Vousden, K.; Littlewood, T.; Evan, G.; Woodgett, J .
R. Site-Specific Modulation of c-Myc Cotransformation by Resi-
dues Phosphorylated in Vivo. Oncogene 1994, 9, 59-70.
(12) (a) Spittaels, K.; Van den Haute, C.; Van Dorpe, J .; Geerts, H.;
Mer-cken, M.; Bruynseels, K.; Lasrado, R.; Vandezande, K.;
Laenen, I.; Boon, T.; Van Lint, J .; Vandenheede, J .; Moechars,
D.; Loos, R.; Van Leuven, F. Glycogen Synthase Kinase-3
Phosphorylates Protein Tau and Rescues the Axonopathy in the
Central Nervous System of Human Four-Repeat Tau Transgenic
Mice. J . Biol. Chem. 2000, 275, 41340-41349. (b) Lucas, J . J .;
Hernandez, F.; Gomez-Ramos, P.; Moran, M. A.; Hen, R.; Avila,
J . Decreased Nuclear â-Catenin, Tau Hyperphosphorylation and
Neurodegeneration in GSK-3 Conditional Transgenic Mice.
EMBO J . 2001, 20, 27-39.
(13) (a) Takashima, A.; Noguchi, K.; Sato, K.; Hoshino, T.; Imahori,
K. Tau Protein Kinase-I is Essential for Amyloid Beta-Protein
Induced Neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 1993, 90,
7789-7793. (b) Hetman, M.; Cavanaugh, J . E.; Kimelman, D.
Xia, Z. G. Role of Glycogen Synthase Kinase-3 in Neuronal
Apoptosis Induced by Trophic Withdrawal. J . Neurosci. 2000,
20, 2567-2574.
(14) (a) Ryves, W. J .; Harwood: A. J .; Lithium Inhibits Glycogen
Synthase Kinase-3 by Competition for Magnesium. Biochem.
Biophys. Res. Commun. 2001, 280, 720-725. (b) Zhang, F.; Phiel,
C. J .; Spece, L.; Gurvich, N.; Klein, P. S. Inhibitory Phosphor-
ylation of Glycogen Synthase Kinase-3 (GSK-3) in Response to
Lithium. J . Biol. Chem. 2003, 278, 33067-33077.
(17) (a) Martinez, A.; Alonso, M.; Castro, A.; Perez, C.; Moreno, F. J .
First Non-ATP Competitive Glycogen Synthase Kinase 3 Beta
(GSK-3 Beta) Inhibitors: Thiadiazolidinones (TDZD) as Poten-
tial Drugs for the Treatment of Alzheimer’s Disease. J . Med.
Chem. 2002, 45, 1292-1299. (b) Conde, S.; Perez, D. I.; Martinez,
A.; Perez, C.; Moreno, F. J . Thienyl and Phenyl a-Halomethyl
Ketones: New Inhibitors of Glycogen Synthase Kinase (GSK-
3b) from a Library of Compound Searching. J . Med. Chem. 2003,
46, 4631-4633.
(18) (a) Leost, M.; Schultz, C.; Link, A.; Yong-Zhong, W.; Biernat, J .;
Mandelkow, E.-M.; Bibb, J . A.; Snyder, G. L.; Greengard, P.;
Zaharevitz, D. W.; Gussio, R.; Senderowicz, A. M.; Sausville, E.
A.; Kunick, C.; Meijer, L. Paullones Are Potent Inhibitors of
Glycogen Synthase Kinase-3â and Cyclin-Dependent Kinase
5/p25 Eur. J . Biochem. 2000, 267, 5983 and references therein.
(b) Mettey, Y.; Gompel, M.; Thomas, V.; Garnier, M.; Leost, M.;
Ceballos-Picot, I.; Noble, M.; Endicott, J .; Vierfond, J .-M.; Meijer,
L. Aloisines, A New Family of CDK/GSK-3 Inhibitors. SAR,
Crystal Structure in Complex with CDK2, Enzyme Selectivity,
and Cellular Effects. J . Med. Chem. 2003, 46, 222-236. (c)
Polychronopoulos, P.; Magiatis, P.; Skaltsounis, A.-L.; Myrian-
thopoulos, V.; Mikros, E.; Tarricone, A.; Musacchio, A.; Roe, M.
S.; Pearl, L.; Leost, M.; Greengard, P.; Meijer, L. Structural Basis
for the Synthesis of Indirubins as Potent and Selective Inhibitors
of Glycogen Synthase Kinase-3 and Cyclin-Dependent Kinases.
J . Med. Chem. 2004, 47, 935-946.
(19) (a) Morgan, D. O. Cyclin-Dependent Kinases: Engines, Clocks,
and Microprocessors. Annu. Rev. Cell Dev. Biol. 1997, 13, 261-
291. (b) Stein, G.; Baserga, R.; Giordano, A.; Denhardt, D. T.
The Molecular Basis of Cell Cycle and Growth Control; J ohn
Wiley & Sons: New York, 1998; p 389. (c) Berthet, C.; Aleem,
E.; Coppola, V.; Tessarollo, L.; Kaldis, P. Cdk2 Knockout Mice
Are Viable. Curr. Biol. 2003, 13, 1775-1785.
(20) Kasuga K.; Hirobe, M.; Okamoto, T. Reaction of N-aminopyri-
dinium Derivatives. XIII. Syntheses of Pyrazolodiazines by
Cyclization of N-aminodiazinium Salts. Chem. Pharm. Bull.
1974, 22, 1814-1826.
(15) Davies, S. P.; Reddy, H.; Caivano, M.; Cohen, P. Specificity and
Mechanism of Action of Some Commonly Used Protein Kinase
Inhibitors. Biochem. J . 2000, 351, 95-105.
(16) (a) Leclerc, S.; Garnier, M.; Hoessel, R.; Marko, D.; Bibb, J . A.;
Snyder, G. L.; Greengard, P.; Biernat, J .; Wu, Y. Z.; Mandelkow,
E. M.; Eisenbrand, G.; Meijer, L. Indirubins Inhibit Glycogen
Synthase Kinase-3 Beta and CDK5/P25, Two Protein Kinases
Involved in Abnormal Tau Phosphorylation in Alzheimer’s
Disease- A Property Common to Most Cycline-Dependent Kinase
Inhibitors? J . Biol. Chem. 2001, 276, 251-260. (b) Leost, M.;
Schultz, C.; Link, A.; Wu, Y. Z.; Biernat, J .; Man-delkow, E. M.;
Bibb, J . A.; Snyder, G. L.; Greengard, P.; Zaharevitz, D. W.;
Gussio, R.; Senderowicz, A. M.; Sausville, E. A.; Kunick, C.;
Meijer, L. Paullones are Potent Inhibitors of Glycogen Synthase
Kinase-3 Beta and Cyclin-Dependent Kinase 5/p25. Eur. J .
Biochem. 2000, 267, 5983-5994. (c) Meijer, L.; Thunnissen, A.
M. W. H.; White, A. W.; Garnier, M.; Nikolic, M.; Tsai, L. H.;
Walter, J .; Cleverley, K. E.; Salinas, P. C.; Wu, Y. Z.; Biernat,
J .; Mandelkow, E. M.; Kim, S. H.; Pettit, G. R. Inhibition of
Cyclin-Dependent Kinases, GSK-3 Beta and CK1 by Hymenial-
disine, A Marine Sponge Constituent. Chem. Biol. 2000, 7, 51-
63. (d) Smith, D. G.; Buffet, M.; Fenwick, A. E.; Haigh, D.; Ife,
R. J .; Saunders: M.; Slingsby, B. P.; Stacey, R.; Ward, R. W.
3-Anilino-4-arylmaleimides: Potent and Selective Inhibitors of
Glycogen Synthase Kinase-3 (GSK-3). Bioorg. Med. Chem. Lett.
2001, 11, 635-639. (e) Cline, G. W.; J ohnson, K.; Regittnig, W.;
Perret, P.; Tozzo, E.; Xiao, L.; Damico, C.; Shulman, G. I. Effects
of A Novel Glycogen Synthase Kinase-3 Inhibitor on Insulin-
Stimulated Glucose Metabolism in Zucker Diabetic Fatty (fa/
fa) Rats. Diabetes 2002, 51, 2903-2910. (f) Bowler, A. N.;
Engelhardt, S.; Sørensen, A. R.; Ursø, B.; Bo¨d-varsdo´ttir, T. B.;
Worsaae, H.; Hansen, B. F.; Kutzhalz, P. 2,4-Diaminothiazoles:
A Novel Class of Glycogen Synthase Kinase-3 (GSK-3) Inhibitors.
Presented at the 11th RSC-SCI Medicinal Chemistry Sympo-
sium, September 9-12, 2001, Cambridge, U.K., 2001. (g) Naerum,
L.; Norskov-Lauritsen, L.; Olesen, P. H. Scaffold Hopping and
Optimization towards Libraries of Glycogen Synthase Kinase-3
Inhibitors. Bioorg. Med. Chem. Lett. 2002, 12, 1525-1528. (h)
Olesen, P. H.; Sørensen, A. R.; Ursø, B.; Kurtzhals, P.; Bowler,
(21) Rolf, P.; William, H. A.; J ohn, H. W.; Marvin, R. F.; Bernard, J .
D.; Robert, L. H.; J ohn, D. P.; Suresh, K. S.; Yang, L. I.
Preparation of Substituted N-phenyl-4-aryl-2-pyrimidinamines
as Mediator Release Inhibitors. J . Med. Chem. 1993, 36, 2716-
2725
(22) Sonogashira, K. Development of Pd-Cu Catalyzed Cross-
Coupling of Terminal Acetylenes with sp2-Carbon Halides. J .
Organomet. Chem. 2002, 653, 46-49.
J M040063I